GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kineta Inc (STU:J75) » Definitions » EV-to-EBIT

Kineta (STU:J75) EV-to-EBIT : -0.29 (As of May. 29, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Kineta EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Kineta's Enterprise Value is €4.68 Mil. Kineta's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €-16.17 Mil. Therefore, Kineta's EV-to-EBIT for today is -0.29.

The historical rank and industry rank for Kineta's EV-to-EBIT or its related term are showing as below:

STU:J75' s EV-to-EBIT Range Over the Past 10 Years
Min: -3.28   Med: -0.35   Max: -0.1
Current: -0.29

During the past 4 years, the highest EV-to-EBIT of Kineta was -0.10. The lowest was -3.28. And the median was -0.35.

STU:J75's EV-to-EBIT is ranked worse than
100% of 423 companies
in the Biotechnology industry
Industry Median: 10.01 vs STU:J75: -0.29

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Kineta's Enterprise Value for the quarter that ended in Mar. 2024 was €4.95 Mil. Kineta's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €-16.17 Mil. Kineta's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -326.67%.


Kineta EV-to-EBIT Historical Data

The historical data trend for Kineta's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kineta EV-to-EBIT Chart

Kineta Annual Data
Trend Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
- - -0.70 -2.43

Kineta Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.34 -0.34 -0.52 -2.43 -0.31

Competitive Comparison of Kineta's EV-to-EBIT

For the Biotechnology subindustry, Kineta's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kineta's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kineta's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Kineta's EV-to-EBIT falls into.



Kineta EV-to-EBIT Calculation

Kineta's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=4.676/-16.171
=-0.29

Kineta's current Enterprise Value is €4.68 Mil.
Kineta's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-16.17 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kineta  (STU:J75) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Kineta's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=-16.171/4.9503
=-326.67 %

Kineta's Enterprise Value for the quarter that ended in Mar. 2024 was €4.95 Mil.
Kineta's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-16.17 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kineta EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Kineta's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Kineta (STU:J75) Business Description

Traded in Other Exchanges
Address
219 Terry Avenue North, Suite 300, Seattle, WA, USA, 98109
Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's asset is KVA12.1, a VISTA blocking immunotherapy.

Kineta (STU:J75) Headlines

No Headlines